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Prolonged sitting significantly disrupts central and peripheral cardiovascular function. 
However, physiological mechanisms explaining these changes are understood in isolation. 
Overall, our understanding of the body’s response to behavioral and environmental stressors is 
poorly defined. It is hypothesized that the combined exposure to prolonged sitting before mental 
stress will lead to greater disruptions in arterial stiffness.  
Six individuals participated in two experimental conditions: two hours of prolonged sitting 
(LONG) and 20 minutes of sitting (SHORT) upright. After sitting in each session, a mental 
stressor was administered. Measures of pulse wave velocity (PWV) and cardiovascular function 
were taken during and after the sitting periods and mental stressor. Brachial-femoral PWV was 
greater (worse) in the SHORT condition (p<0.001, ES=-1.81). Femoral-ankle PWV was greater 
in the LONG condition (p=0.025, ES=0.59). 
Prolonged sitting and mental stress in combination acutely worsen peripheral arterial 
stiffness. Precursory changes in cardiovascular function may explain these changes in 
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CHAPTER I: INTRODUCTION 
 
Stress, sedentarism, and cardiovascular diseases (CVDs) in the United States have 
reached pandemic proportions1–3 and research has recently shown how our actions immediately 
impact cardiovascular function. Cardiovascular diseases and adverse cardiovascular events 
consistently rank as the leading cause of death in the United States 3,4 and worldwide5,6. While a 
sizable portion of an individual’s cardiovascular profile is genetically predetermined7,8, specific 
health behaviors can significantly affect an individual’s risk for the development of CVD’s9–12. 
For example, chronic mental stress (MS) and a lack of physical activity (PA) are known to 
negatively impact an individual’s cardiovascular health cutely 13–15 and chronically 16,17 The 
pathways in which mental stress impacts the cardiovascular system (CVS) acutely are well 
documented16,18,19, and the dangers of chronic stress are well known20,21. Significant, acute 
disruptions to the vasodilatory properties of the endothelium have been cited to occur after 
bouts of sitting lasting as little as one hour22–24. Responding to the sedentarism epidemic with 
research-guided public health will first require a clearer understanding of these acute 
physiological changes. Furthering our understanding of how these stimuli impact the CVS and 
establishing these recommendations will be beneficial for the maintenance of cardiovascular 
health for at-risk populations like the average “white-collar worker.”  
Most white-collar workers exist in a high-stress work environment characterized by 
extensive desk and screen time. If researchers are to provide strategies to mitigate the negative 
effects of MS and prolonged sitting to this workforce, further research is necessary on these 
factors’ physiological disruptions. This study observed how measures of central and peripheral 
cardiovascular health are disrupted by MS with or without exposure to preceding prolonged 
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sitting. Novel measures like pulse wave velocity (PWV), a measure of arterial stiffness (AS), will 
be coupled with other variables collected by non-invasive techniques to obtain the desired 
cardiovascular profile of the white-collar participant. The physiological mechanisms connecting 
prolonged sitting and MS to changes in the CVS are understood. However, the interactions 
between these cardiovascular responses are relatively unknown. Based on a review of the 
present literature, it is hypothesized that exposure to prolonged sitting will worsen the 
cardiovascular disruptions caused by exposure to a standardized research mental stressor.  
Specific Aim 1: To observe the cardiovascular response and changes in arterial stiffness to 
prolonged uninterrupted sitting in the “white-collar worker” population: physically inactive middle-
aged adults at heightened risk for cardiovascular diseases. 
Specific Aim 2: To observe the cardiovascular response and changes in arterial stiffness to a 
mental stressor with or without previous exposure to prolonged uninterrupted sitting.  
Strategy: A two-condition crossover trial in which participants were exposed to the mental 
arithmetic test (MAT) either after two hours of sitting (LONG condition) or 20 minutes of sitting 
(SHORT condition). Exposure to the MAT will be time-matched to maintain internal validity. 
Central and peripheral pulse wave velocity were used as surrogate measures for arterial 
stiffness. Data from this lab group and scientific literature supports the usage of brachial-femoral 
PWV, carotid-femoral PWV, and femoral-ankle PWV as viable arterial stiffness outcomes. Data 
were collected at the beginning of the sitting periods in each experimental condition (PRE-SIT). 
In the LONG condition, arterial stiffness will be measured at the end of the sitting period to 
address specific aim 1 (POST-SIT). To address specific aim 2, PWV will be measured 
immediately after completion of the MAT, every 5 minutes post-MAT for 20 minutes, and 30 
minutes post-MAT. Data from these time points were compared to PRE-MS values in both 
conditions in a mixed model.  
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Hypothesis: The central and peripheral cardiovascular responses to mental stress will be 
worsened after exposure to prolonged sitting.   
 
ASSUMPTIONS, DELIMITATIONS & LIMITATIONS 
Assumptions 
 
1. Participants truthfully answered medical screening questionnaire 
2. Participants followed pre-assessment guidelines 
3. Placement of VICORDER® cuffs was similar between two visits and recorded similar 
arterial segments 
4. Mental arithmetic test adequately “stressed” out the individual 
Delimitations 
 
1. Researchers encouraged little to no movement by the participant to ensure data is of 
high quality 
2. All participants had a similar 24-hour dietary intake profile with the usage of a 
standardized meal 
3. Exposure to the mental stressor was at a similar time of day for both conditions 
4. A sitting period of two hours is shown, according to literature, to cause significant 
disruptions in the cardiovascular system 
Limitations 
 
1. Due to the COVID-19 pandemic, investigators were unable to acquire the number of 
participants for adequate statistical power.  
2. Familiarization to mental stressor may occur between experimental conditions. Elicited 









CHAPTER II - REVIEW OF LITERATURE 
 
INTRODUCTION TO TOPIC 
 
This literature review will begin by explaining the prevalence of prolonged sitting and 
chronic MS on a national scale and how these factors impact the national wellness and 
productivity. Only recently has the general public become aware of the problems prolonged 
sitting and excessive MS impose on individual health. Awareness is the first step in attempting 
to combat the scourge of prolonged sitting on cardiovascular health, but in order to take action, 
continued research on the physiological mechanisms both prolonged sitting and mental stress 
take to impact the cardiovascular system is necessary. Without a foundation of knowledge, 
organized guidelines for effective action cannot be constructed. Therefore, this review will reveal 
what we do and do not understand about behavioral factors and their acute and chronic impacts 
on cardiovascular function and structure. A sizable body of literature has shown the acute 
impact of these factors on cardiovascular health, but significant gaps in knowledge regarding 
more chronic impacts and potential compounding effects show the need for further investigation. 
 
IMPORTANT DEFINITIONS 
Sedentary Behaviors (SB) 
  
Sedentary behavior defines the lifestyle of sedentarism. In the United States, with the 
increasing availability of short-term gratification, reported physical has dropped, and 
sedentarism has risen25. For the past two decades, researchers have been contributing to a 
body of literature defining and denouncing a sedentary lifestyle and sedentary behaviors like 
prolonged sitting11,13,26–28. A review committee under the advisement of the Department of 
Health and Human Services concluded that “moving more and sitting less” is one of the most 
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important actions a person can do to improve their health29. A separate study found that a 
lifestyle centered with regular exercise cannot overcome the negative effects of excessive being 
sedentary30. Right now, identifying and reducing time spent sedentary is vital for the 
maintenance of national public health. The Sedentary Behavior Research Network defines SB 
as “waking behavior characterized by an energy expenditure ≤1.5 metabolic equivalents 
(METs), while in a sitting, reclining or lying posture”31. While this definition is objective and easily 
defined for exercise physiologists, the general public is less knowledgeable on specific 
terminology.  Relevant to not only this study, but to the middle-aged populous, our target 
population, is the fact that consistent sedentarism leads to elevated resting heart rate, blood 
pressures, and potentially lipid values like high-density lipoprotein (HDL) levels32,33. Defining SB 
in this manner while also adhering to gold standard definitions in literature will more clearly 
convey the harm that actions like prolonged sitting and physical inactivity have on the body. 
 
Mental Stress (MS) 
  
Mental stress seemingly defines a way of life for most middle-aged Americans. In a 
review of cardiovascular responses to acute and chronic levels of stress, Dimsdale et al. define 
“stress” as “the organism’s response to challenge”21. This ability to identify and respond to 
environmental challenges or stimuli is an essential tool for survival against perceived “threats.” 
However, when “threats” are the mental toll of the daily workday, and stress pathways are 
constantly activated, cumulative damage to the CVS occurs. The stress reactivity hypothesis 
has allowed us to make this connection between psychological stressors and strain on 
cardiovascular function. This theory states individuals with excessive cardiovascular responses 
to MS (e.g., large spikes in BP with sustain elevation) are more prone to the development of 
CVDs34. Researchers admit, though, that the cardiovascular response to a specific MS is unique 
and contains low generalizability to all types of stressors. It is still unknown how cardiovascular 
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reactivity changes over time, how it is influenced by behavioral factors like exercise or 
sedentarism, or how it is affected by other mental stressors. This study will explore how 
sedentary behaviors like PS affect the body’s capabilities to interpret and respond to mental 
stress. 
 
NATIONAL RISKS: MENTAL STRESS AND PROLONGED SITTING 
 
The economy of the 21st century demands more “white-collar” jobs than any other period 
of human progress in history. Unlike our more industrial ancestors, a larger portion of the 
workforce must now sit at desks and complete mentally rigorous tasks rather than physically 
move and actively “work”35. Also, most adults in affluent environments like the United States 
spend 70% of their waking hours seated and sedentary36. Prolonged sitting is an example of 
sedentary behavior, and its prevalence significantly impacts the national healthcare system. 
Sedentarism and physical inactivity have been shown to significantly increase an individual’s 
risk for CVDs11,37,38. More seriously, the health benefits garnered from an exercise-centered 
lifestyle are lost with significant amounts of prolonged sitting30. Worryingly, with increased 
access to smart devices and a new, tech-centered economy, this behavior has seen increased 
prevalence and is expected to grow 25,39. The American Heart Association (AHA) estimated that 
direct costs in 2017 totaled $300 billion dollars on the American economy with the value 
doubling at least by the year of 2035 4. Combatting this burden requires a more focused 
research effort to better understand the health behaviors the general public can collectively take 
to reduce the prevalence of CVDs.  
In addition to physical inactivity, the pursuit for greater strides in business and 
technological advancement has also imposed high levels of mental stress and cognitive strain 
on the working population. The burden of chronic stress in America has reached critical levels40. 
This greater stress load upon the collective workforce may indirectly exaggerate the problems of 
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an already strained healthcare system. These health burdens are especially true for middle-
aged Americans, the subpopulation most likely to experience this high-stress environment. 
Chronic mental stress puts these individuals at greater risk for the development of cancers and 
cardiometabolic conditions16,21,41. In comparison to low-stressed individuals, this group also 
report lower quality of life and lower energy21. Instead of slowing the pace of human progress, 
more research should be completed to discover techniques that mitigate stress’s harm on the 
CVS and maintain physical and mental wellbeing.  
 
ASSOCIATIONS BETWEEN CHRONIC SEDENTARY BEHAVIOR AND CVD 
  
Sedentary behaviors contribute significantly to the development of CVDs. This 
connection began with Moris et al. in 1958 with the observation that bus drivers were twice as 
likely to be diagnosed with CVDs than the more active job of the bus conductor. Since these 
preliminary findings, our understanding of the causality between physical inactivity and CVDs 
has become stronger and more granular. We’ve learned that a calculated risk for CVDs is far 
more complex with factors like genetic predisposition, age, stress, diet, and physical inactivity, 
all acting as contributing factors. Before the development of CVDs, changes begin with 
progressive changes in bodily characteristics. Those who are less active lose muscle mass, 
increased fat mass, and more developed disruptions in cardiovascular function over time42. 
These are the long-term physiological changes that are the result of the unfavorable 
predisposition for these conditions43. A landmark study found the physical inactivity 
independently account for 6-10% of all cases of non-communicable disease of the heart, 
metabolic conditions, and even some cancers44.  
 
ACUTE PROLONGED SITTING IMPAIRS CARDIOVASCULAR FUNCTION 
 
Research has established that significant changes in cardiovascular function due to PS 
begin in the lower limbs. The phenomenon of venous pooling is the collection of blood in the 
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legs due to the added effect of gravity and is visualized as the first physiological change in 
Figure 1. The pumping action from the lower limb musculature is lost, and the blood fails to 
exceed the force preventing circulation back to the heart. A decreased return of deoxygenated 
blood to the inferior vena cava will translate to decreases in cardiac output (CO). The heart 
manages to compensate by increasing heart rate, but with these changes and an excessively 
high work rate, cardiac function in the future may be lost. In addition to acute changes in cardiac 
function, the decreased CO and reduced blood blunts shear stress and fails to dilate constricted 
vessels, thereby increasing resistance to blood flow 14,45. Prolonged sitting imposes these 
significant changes in cardiac function with durations as short as one hour 14,22,23. More novel 
measures assessing cardiovascular function and structure like pulse wave velocity (PWV), 
pulse wave analysis (PWA), and augmentation index (AIx) have been critical in this relatively 
new understanding that a lifestyle of sedentarism leads to higher risks of CVDs, other chronic 
diseases, and early mortality 12,46–48. 
Prolonged sitting also influences the function of the most minuscule endothelial 
mechanisms. These changes are relatively small, but these failures in regulatory mechanisms 
are hypothesized to translate to greater risk for CVDs. These macroscopic changes are due to 
underlying physiological mechanisms that describe the regulatory efforts the CVS makes to 
maintain homeostasis and demands of normal life. A leading hypothesis connects significant 
changes in blood flow to the most miniscule functions of the inner layers of our peripheral 
endothelium 49–52 The connecting force that fulfills this proposed relationship is shear stress, 
defined as the force experienced by the endothelium of blood vessel when erythrocyte flow 
against the individual cells. Shear stress stimulates endothelial cells to release of nitric oxide 
(NO), a powerful vasodilator that expands the lumen of a blood vessel when blood pressure due 
to heightened blood flow is hypertensive. Blood flow undisturbed by prolonged sitting generates 
adequate levels of shear stress and nitric oxide to maintain regular peripheral circulation and 
cardiac function. It is hypothesized that prolonged sitting due to the venous pooling of blood in 
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the lower limbs is the first disruption in the cardiovascular system that blunts this shear stress 
mechanism and will eventually lead to increased arterial stiffness, visualized as the final steps in 
Figure 1. 
 
Gaps in Knowledge 
  
Despite the formation of two distinct physiological mechanisms, specifics of these 
changes are still unclear. It is still unknown if there is a “dose-dependent” relationship between 
prolonged sitting and disruptions in cardiovascular function. For example, does PWV increase 
linearly with increasing time in prolonged sitting, or is there a “ceiling” value after a certain 
amount of exposure? Workers in certain occupations may have to maintain a seated position for 
several hours every day of the workweek, potentially accruing detriments to cardiovascular 
function and accelerating atherosclerosis. Also, there is no one clearly effective intervention to 
mitigate the CV effects of prolonged sitting that is also easy and simple to complete. Calf 
pumping, “fidgeting,” and standing are examples of previously explored solutions, but success 
has been limited23,51,53,54. 
 
ACUTE MENTAL STRESS IMPAIRS CARDIOVASCULAR FUNCTION 
 
Mental stress (MS) is manifested physiologically through two pathways: neural and 
hormonal. Through these pathways, environmental stressors can influence and disrupt the 
continuous input of the autonomic nervous system (ANS) provides to the CVS. The ANS is split 
into two subbranches: the sympathetic nervous system (SNS) and the parasympathetic nervous 
system (PNS). Both branches of the ANS serve the heart and other portions of the central 
circulatory system continuously for regulatory purposes. A surrogate measure to assess this 
function of the ANS is heart rate variability (HRV), defined as the time between RR intervals on 
an EKG. Larger averages of HRV over a period of observation is indicative of greater ANS 
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activation or cardiac exertion55. The SNS and PNS also provide the function of vasoconstriction 
and vasodilation in response to metabolic demands, respectively. In the event of a mental 
stressor, these branches naturally alter the endothelial tone and cardiac function, thus 
manipulating measures of HR and BP. These physiological changes are necessary for survival 
and adaptation, but excessive activation of these neural pathways will lead to hypertensive 
conditions in the CVS and damaged vasculature.  
Stress also influences the CVS through the hypothalamic-pituitary-adrenal (HPA) axis. 
The presence of a stressor activates this pathway to secrete a variety of catecholamines 
(epinephrine, norepinephrine) and glucocorticoids (cytokines, cortisol). Each chemical pathway 
maintains a functional purpose to manage the new loads the perceived stressor has on the 
body. These pathways are essential to meeting the demands brought on by acute stimuli. From 
these pathways come macroscopic alterations in blood pressure, heart rate, and subclinical 
measures found from PWA. These changes are natural and essential for an appropriate 
response to stressors. Chronic activation, however, of the HPA axis leads to cardiovascular 
dysfunction56. Hypercortisolism, for example, leads to hypertensive conditions throughout the 
peripheral vasculature10,19. Heightened cytokine levels in the bloodstream also trigger excessive 
cardiovascular stress through an immune response that accelerates atherosclerosis57.  
 
Gaps in Knowledge 
  
The perception and reaction to a stressor are unique to each individual. It is still unclear 
how MS impacts all portions of the CVS, including cerebrovascular structure and function. A 
colloquial understanding of stress and cognitive performance believes that excessive stress will 
lead to decreased mental performance. Unfortunately, a more comprehensive, physiological 
understanding of this decrease in cognition is less understood. It would be beneficial to 
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elucidate these pathways to either assist in maintaining cognitive performance or preventing the 
harm to cerebrovascular structure and function due to acute or prolonged mental stress.  
 
PROPOSED COMBINATION EFFECT 
  
Both prolonged sitting and MS operate through separate mechanisms to impair 
peripheral and central cardiovascular function. Prolonged sitting, a sedentary behavior chosen 
by the individual, will lead to more direct changes in the function of the CVS. Mental stressors, 
in contrast, will affect cardiovascular function across different pathways and relative in strength 
amongst individuals58. Perception of stress is variable amongst individuals, and the introduction 
of a light mental stressor will therefore lead to non-uniform changes in the CVS. Regardless, as 
discussed, MS operates through neural and hormonal pathways to disrupt cardiovascular 
function. Using the literature as a guide, the proposed combination effect is visualized in Figure 
1. The diagram generalizes the pathways these adverse behaviors and environmental factors 
take and hypothesizes that heightened central and peripheral arterial stiffness is the result of 
repeated exposure to both prolonged sitting and MS. This study is the first to hypothesize that 
the cardiovascular response to MS will be worsened if the individual is first exposed to a bout of 
prolonged sitting. If this protocol provides preliminary evidence for this combination effect, a 
novel understanding that specific behavioral and environmental stressors may uniquely interact 
to impose unique disruptions in cardiovascular function will be understood.  
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FIGURE 1. A visualization of the pathways prolonged sitting and mental stress (MS) 




Study Design Considerations 
  
Several study designs have been considered to achieve the goals of this research 
project. The selection of the overall structure for this study design was based on considerations 
for convenience to the participants, minimization of influence by potential covariates, and ease 
of protocol completion by the investigators. A cross-sectional study may seem most convenient 
due to the need for one experimental session. However, one data point for each participant 
would make controlling for covariates difficult and comparison between groups receiving and not 
receiving exercise difficult. A randomized control trial (RCT) is the gold standard for clinical 
physiology research, but larger sample sizes required for these studies make completion 
unfeasible. Participants in an RCT may also make health decisions between experimental 
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sessions that will skew data and make comparisons between groups impossible. Therefore, a 
crossover design was chosen to allow each participant to act as their own control. Within-
subject data also helps eliminate the effects of most confounding anthropometric variables. 
Measures of central and peripheral cardiovascular function will be compared between the 
SHORT and LONG conditions to assess the potential influence of prolonged sitting on the 




Arterial stiffness is a novel form of analysis to assess the health and elasticity of internal 
layers of larger arteries. Structural changes like the formation of fatty are the precursors for 
increases in arterial stiffness and higher risk for acute cardiovascular events and the 
development of CVDs59–61. This study has chosen AS as its marker of cardiovascular health and 
concluding outcome in Figure 1 because previous research has tied its increase to a heightened 
risk for CVDs46. Pulse wave analysis and PWV is the gold standard for measurement of arterial 
stiffness Through the assessment of systolic pressure waves generated from the heart and 
throughout the arterial tree59. The pressure waves traveling further down arterial pathways or 
reflecting backward, generating a composite waveform acquired from PWA. Pulse wave velocity 
is mathematically defined as the linear distance between measurement sites divided by the 
pulse transit time (PTT). Pulse transit time is defined as the time between the foot of the 
composite pulse waveforms collected at the two separate measurement sites and is collected 
automatically by an experimental device. The variable, augmentation index (AIx) is the percent 
differences in height between the first and second peaks on the composite waveform and is a 
key measurement for arterial stiffness 62. Augmentation index, along with relative and absolute 
changes in central and peripheral PWV, will provide insight on how prolonged sitting and MS 
worsen acute arterial health and function. Several devices have been used by this lab group to 
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conduct PWA. The VICORDER® device (Vicorder, SMT Medical), has been chosen for this 
protocol due to its relative ease of use and ability to automatically calculate measures relative to 
this protocol. Like several other gold standard non-invasive devices, the VICORDER® system is 
non-invasive to the participant and allows calculation of central and peripheral PWV as well as 
AIx relatively simple. Other devices have been considered to collect our primary outcomes. 
SphygmoCor XCEL is a tonometer-based system that has been validated for measures of 
central PWV. However, proper usage of this system requires extensive training and guidance by 
manufacturer personnel. 
Venous pooling in the lower limbs is the first physiological change that begins the 
cascade of cardiovascular disruptions, as shown in Figure 1. Data must be collected to confirm 
this chain of disruption is occurring to allow sound conclusions for the research question. 
Therefore, a simple non-invasive assessment hypothesized to observe blood pooling will be 
conducted. Investigators will measure calf circumference before and after the sitting periods of 




The age range of 35-59 was chosen due to the increased risk for CVDs this population 
faces, especially after 5063. This increased risk is due to the natural decline in the function of the 
heart over his or her lifespan. This age group encapsulates the average American “white-collar 
worker” that spends most of their workday seated at a computer screen. A vast majority of 
individuals in the United States report some physical activity, but do not meet exercise 
guidelines set by the American College of Sports Medicine (ACSM) according to subjective and 
objective data64. Therefore, to be reflective of the general American population, individuals must 
report levels of physical activity below the ACSM guideline of 150 minutes of exercise per week 
will be included in this study. Individuals who report a current diagnosis or history of CVD’s 
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(peripheral artery disease, coronary artery diseases, etc.), cardiovascular events (myocardial 
infarction, stroke, etc.), and/or metabolic syndromes (type I or II diabetes) will not be included in 
this study. Abnormal physiology of the CVS due to these conditions will skew outcomes for this 
study and not be reflective of the American population. We will not impose restrictions on 




Linear mixed models were chosen to analyze data relevant to both scientific aims due to 
its ability to address all aspects of the study design and data collection. We considered 
dependent t-tests to assess changes after prolonged uninterrupted sitting in the LONG 
condition. However, the primary and secondary outcomes of this study are influenced by the 
time of collection of hemodynamic covariates like mean arterial pressure (MAP). Therefore the 
mixed model option was chosen and MAP was included as a covariate to account for its 
documented influence on measures of PWV65,66. Linear mixed models were also chosen to 
account for random effects (subject) and random intercepts. Use of a linear regression model 
could analyze for significant differences amongst the fixed effects experimental time points and 
experimental conditions. However, the regression model would have failed to explain the 
inherent random differences amongst subjects that would be sampled from the population. 
Finally, mixed models were selected due to their ability to retain data in the event of missing 
values from a singular timepoint. Unlike, for example, a repeated measures ANOVA that 
requires a balanced array of data amongst subjects, a linear mixed model is capable of 









TABLE 1. Pre-assessment guidelines 
Consideration Explanation Control Procedure 
Standardized beginning 
time for all experimental 
sessions 
Prevent activities of daily 
living from interfering 
with data quality 
All experimental sessions will 
commence between 6:00-8:00 AM 




effects of vigorous PA on 
CVS from influencing 
data 
The individual will be reminded the 
day before an experimental session 
to refrain from vigorous physical 
activity 
Prevention of alcohol and 
caffeine consumption 
Prevent prolonged 
effects of these 
consumables from 
influencing CVS and 
data 
The individual will be reminded the 
day before an experimental session 




Ensures all participants 
are similar in food 
consumption profile for 
at least 24 hours 
Included subjects will be provided a 
free microwave meal to be 
consumed for dinner before the 





Investigators followed established screening procedures to recruit a homogenous 
sample group. The specific aims of this study are primarily concerned with observing 
physiological responses to a behavioral (prolonged sitting) and an environmental (MAT) 
stressor. A group relatively similar in age, activity, and health simplifies analysis and 
strengthens the validity of experimental conclusions. A challenge investigators faced during 
study design was the standardization of the response to the MS. Mental alertness is likely 
different at different hours of the day. In response, to maintain internal validity, all participants 
initiated both experimental conditions within 30 minutes of one another, and all experimental 







TABLE 2. Inclusion criteria 
Criteria Method Rational 
Aged 35-59 years old Initial email contact 
screening 
This age range is the standard 
definition of middle-aged adults. It is 
understood that individuals over age 
59 are characterized by significantly 
worse cardiovascular health 
≤150 minutes per week of 
self-reported physical activity 




The cutoff of 150 minutes is sourced 
from ACSM physical activity 
guidelines. All individuals in this study 
being underneath this recommendation 
control their potential response to a 
bout of sedentary activity 
 
 
TABLE 3. Exclusion criteria 
Criteria Method Rational 
Pregnant Initial email contact 
screening; familiarization 
session screening 
Women undergo significant 
physiological changes during 
pregnancy. Different 
hormonal profiles will cofound 
cardiovascular outcomes 
Presently smoking Initial email contact 
screening; familiarization 
session screening 
Smoking is understood to 
significantly decrease 
cardiovascular health. This 
study aims to characterize 
physiological responses in a 
healthy, homogenous 
population 
Taking medication known to 
alter cardiovascular function 





These drugs will significantly 
alter cardiovascular 
outcomes in this study. A 
homogenous population is 
required to answer research 
questions in this study 
Diagnosed with 
cardiometabolic diseases 
Initial email contact 
screening; familiarization 
session screening 
Examples: PAD, CAD, 
T2DM 
These conditions significantly 
disrupt healthy 
cardiovascular function. A 
homogenous population is 
required to successfully carry 




Sex as a Biological Factor 
  
This study sought to equally split the sample group for ten males and ten females to 








Maintaining the internal and external validity of collected data allowed maximum 
generalizability to the white-collar worker population. Internal validity was maintained by only 
allowing the primary investigators to collect and analyze data to assure quality and consistency. 
Data outputs were inspected after completion of each experimental session to ensure high-
quality data was collected. All data collection was completed while the participant is in a seated-
upright position 
 
POTENTIAL CHALLENGES & ALTERNATIVE STRATEGIES 
 
 Internal validity was maintained by assuring that for each participant in this study, 
exposure to the MS in the two experimental conditions was within 30 minutes of one another for 
the time of day. For example, if participant one was exposed to the MAT at 8:30 AM for the 
LONG condition, the participant would have needed to be scheduled to between 7:30-8:30 AM 
for the SHORT condition to ensure exposure to the MAT falls within the 8:00-9:00 AM window. 
This time consideration provided an extra degree of standardization by maintaining the time at 
which the individual is exposed to the laboratory environment. While the SHORT and LONG 
conditions were not time-matched amongst all participants, the investigators utilized 
accelerometers affixed to the wrist to assess and control for potential activity completed before 
experimental conditions.  
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Unmet Recruitment Targets 
 
Due to the existing pandemic, researchers were unable to adequately recruit and test 
individuals to acquire adequate statistical power on a significantly reduced timeline. This lack of 




TABLE 4. Project timeline and milestones 
Activities Start Date End Date 
Pilot Testing October 15, 2019 January 9, 2020 
Equipment SOP’s current May 12, 2019 August 28, 2019 
Protocol/IRB  February 12, 2019 October 11, 2019 
Staff training August 2018 November 1, 2019 
Study forms/ database February 12, 2019 Ongoing 
Set-up filling system (OneDrive) October 11, 2019 December 19, 2019 
Recruitment November 2019 March 9, 2019 
Data collection December 5, 2019 March 9, 2019 
Aim 1 analysis March 16, 2020 March 31, 2020 
Aim 2 analysis March 16, 2020 April 1, 2020 
Hand Document to Committee APRIL 27, 2020 
Defend MAY 4, 2020 
Respond to defense changes May 6. 2020 May 15, 2020 
Submit thesis to graduate school May 18, 2020 May 31, 2020 
Authorship order agreement May 5, 2020 May 19, 2020 
Prepare Manuscript June 1, 2020 July 31, 2020 
 
SUMMARY 
Why is This Study Needed? 
 
Investigators were unable to identify an existing study that attempted to research the 
cardiovascular response to prolonged sitting and an MS in succession. This research study 
attempted to contextualize our understanding of prolonged sitting in a setting that more closely 





What is Known 
 
Prolonged sitting significantly impairs cardiovascular function and repeated exposure to 
sedentary behaviors is known to increase the risk for CVD’s. Physiological mechanisms defining 
how prolonged sitting and MS impair cardiovascular function are understood in isolation and 
laboratory settings.  
 
What is Not Known 
 
The interactions between prolonged sitting and MS on measures of cardiovascular 




More research is required on cardiovascular health in at-risk populations like the white-












Ten healthy adults were recruited for this study. The population of interest in the Chapel 
Hill, NC area was notified via flyers, university emails, and preexisting email listservs. For 
inclusion into this study, subjects had to be 35-59 years old and must have reported present 
habitual physical activity below ACSM guidelines of 150 minutes per week. Exclusion criteria set 
for this study were: currently pregnant, smoking, taking medication known to alter 
cardiovascular function, or diagnosed with any known cardiometabolic diseases. Prior to the 
commencement of experimental sessions, subjects were familiarized with the protocol and 
directives of this study and completed written informed consent. This study was approved by the 
Institutional Review Board of the University of North Carolina at Chapel Hill and is in accordance 




This study was a randomized crossover trial with two conditions: (1) SHORT – 
completion of 20 minutes of sitting with exposure to a mental stressor and (2) LONG – 
completion of two hours of sitting followed by exposure to the same mental stressor. All 
experimental visits were conducted in the morning starting between 6:00-10:00 AM to minimize 
the effects of daily activities on data quality. For the purpose of maintaining external validity, the 
time of exposure to the MS in the second condition was to be administered within a 30-minute 
window of the first condition’s MS (e.g. Exposure to MS was at 9:00 AM in the LONG condition 
and must be between 8:45-9:15 AM for the SHORT condition). A visualization of the described 
protocol is shown in Figure 2. 
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FIGURE 2. Experimental protocol. First experimental condition for all participating 
subjects is randomized according to stated randomization procedures.  
Visit 1: Familiarization 
  
Potential subjects interested in participation arrived at the Applied Physiology Laboratory 
(APL) for discussion with the primary investigators of the study. Subjects interested in 
participation after initial discussions were asked to complete a general medical questionnaire 
that asked for current health behavior habits and medical history (APPENDIX A). Those eligible 
for participation in this study after inclusion/exclusion completed written informed consent (See 
APPENDIX B). The investigators provided descriptions of each experimental device used in the 
protocol, how they are used in this study, and how and when they were to be affixed to their 
body for data collection. Before leaving the APL, subjects were informed of pre-assessment 

























Every 5 minutes after MS
Every 5 minutes after MS
Session Complete
 ( t = 165 min)
-10’ -  PWV/A (3)
-110’ -  PWV/A (3)
-10’ -  PWV/A (3)
Continuous data













• No vigorous exercise 24 hours prior to time of experimental session 
• No alcoholic consumption 24 hours prior to time of experimental session 
• No caffeine consumption 12 hours prior to time of experimental session 
• Consumption of a free standardized meal before beginning of the fasting time 
The participant and investigators would then schedule the date and time of the first experimental 
session. The first experimental session must be at least 24 hours after the familiarization 
session.  
 
Visits 2 & 3: Experimental Visits 
  
After arrival to the APL, investigators discussed with the participant if he or she adhered 
to the previously described pre-test behavioral restrictions. If the subject did not adhere, 
investigators rescheduled the experimental visit at the earliest convenience to the subject and 
research team. Once adherence was assured, collection of basic anthropometrics (weight, 
height, BMI, age, etc.) was completed by the primary investigators. A randomization software 
(www.randomizer.org) was previously utilized to determine if the present participant would start 
the experimental portion of this study with either the SHORT or LONG protocol.  
 In both protocols, participants rested in a fully supine position for at least 10 minutes. 
During this time, investigators affixed VICORDER® cuffs and EKG leads to the participant. Cuff 
placement on either the left or right side of the body was randomized amongst participants in 
this study using the same randomization software. Once these devices are functioning and the 
individual has had sufficient rest, subjects were shifted into an upright seated position for either 
20 (SHORT) or 120 (LONG) minutes. VICORDER® data collection was conducted after ten 
minutes of sitting in each condition to achieve baseline measures. At the end of sitting periods in 
both SHORT and LONG, participants were exposed to an MS using the standardized mental 
arithmetic test (MAT). Completion of the MAT, the VICORDER® protocol was completed for 
 24 
central and peripheral PWV and PWA (See Figure 2 for estimated timepoints). Subjects were 
maintained in the seated upright position during these testing protocols. Previous studies have 
chosen to complete PWV and PWA assessment in the supine position; however, we chose to 
maintain the seated position throughout experimental conditions to minimalize the known effect 
of changes in body position on central and peripheral hemodynamics68. In both conditions, the 
option to watch a low-stimulation nature documentary (Kingdom of the Skies, PBS) during these 
sitting periods was offered to prevent boredom and discomfort by the participant. At the end of 
the first experimental session, participants were asked to schedule the second experimental 
session which must be at least 48 hours after the first session. Participants were thanked for 
their cooperation and would receive a report of their cardiovascular health as measured by the 
experimental devices after the completion of the second and final experimental session.  
 
Mental Stress – Mental Arithmetic Test (MAT) 
  
The mental arithmetic test (MAT) was the standardized and valid psychological stressor 
for this study. The test was approximately five minutes in duration. Participants were instructed 
to subtract seven or 13 from a four-digit number as many times as possible for one minute. The 
initial number for subtraction was changed every minute during the test. Participants were asked 
to subtract in time with a metronome set to 22 bpm (increased by 2-3 bpm with every minute) to 
increase the cognitive stress. Amount of subtractions was not recorded as an experimental 
measure. See APPENDIX D for full testing documents. The visual analog scale (APPENDIX E) 
and Borg Category with Ratio properties (CR10, APPENDIX F) were included in the testing 
protocol to assess post-MAT levels of distress. The fogginess scale utilizes a 10-point Likert 
scale from 0 “not foggy-very focused” to 10 “maximal fogginess – cannot focus.” This test was 
administered in a seated position at PRE-SIT, POST-SIT, and post-MAT experimental time 
points in both experimental conditions 
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EXPERIMENTAL MEASURES 
Primary Outcome: Brachial-Femoral Pulse Wave Velocity (bfPWV) 
 
Central and peripheral PWV were assessed using the VICORDER® device. This system 
acquired the primary outcomes using an automated, non-invasive blood pressure cuff system. 
The primary outcome for this study is brachial-femoral pulse wave velocity (bfPWV), a reliable 
measure of central arterial stiffness according to previous research69 and unpublished data from 
this lab group. Unpublished findings from this lab group indicate bfPWV as a reliable measure 
for central arterial stiffness in the seated upright position. This measure is acquired by wrapping 
VICORDER® blood pressure cuffs around the participant’s brachial (b) artery site and ipsilateral 
thigh for the femoral (f) artery site. Pulse transit time is calculated automatically by the 
VICORDER® system. Straight-line distances between measurement sites were recorded 
according to manufacturer guidelines to allow the device to calculate bfPWV: the distance 
between the sternal notch and umbilicus. The measure was taken after ten minutes of sitting in 
both SHORT (PRE-MS) and LONG (PRE-SIT) in triplicate with the closest two values being 
averaged together and recorded for further analysis. After 100 minutes of prolonged sitting in 
the LONG condition (POST-SIT/PRE-MS), bfPWV was measured again in triplicate. After 
exposure to the MS, bfPWV was measured in triplicate immediately after (0-MS) the test and 
five, ten, 15, 20, and 30-minutes post-test (5-MS, 10-MS, 15-MS, 20-MS, 30-MS, respectively) 








Secondary Outcomes: Additional Measures of Central and Peripheral Cardiovascular 
Health 
 
Additional PWV measures were taken by the VICORDER® device using three other 
sites/arteries: carotid (c), femoral (f), and ankle (a). Two measures of PWV were acquired from 
these sites: one for peripheral AS, femoral-ankle PWV (faPWV), and one for central AS, carotid-
femoral PWV (cfPWV). Femoral-ankle PWV has been used in previous studies completed by 
this lab group to assess peripheral arterial stiffness. The straight-line distance used for faPWV is 
between the superior borders of the pressure cuffs placed over the femoral artery and ankle 
site. Due to experimental error, recorded distances for this arterial stiffness outcome were 
invalid. All transit time data for this outcome were divided by a common distance to investigate 
relative changes. Carotid-femoral PWV, a surrogate for aortic arterial stiffness, has been a 
clinically significant marker of cardiovascular risk70. The straight-line distance for this outcome is 
the distance from the sternal notch to the superior border of the femoral cuff minus the distance 
between the carotid artery and the sternal notch. Measurements of cfPWV and faPWV were 
taken in triplicate alongside bfPWV after ten minutes of sitting in both the SHORT and LONG 
conditions and at minute 100 in the LONG condition. These outcomes were measured again in 
triplicate approximately 30 minutes post-MS in both experimental conditions.  
The VICORDER® device conducted PWA to collect augmentation index (AIx), estimated 
central and peripheral systolic blood pressure (SBP, cSBP), stroke volume (SV), cardiac output 
(CO), and total peripheral resistance (TPR) consecutively with measures of bfPWV. 
Augmentation index is dependent on the pulse waveforms acquired from PWA and provides 
supplemental information on arterial stiffness and potential risk for CVD’s71. Completion of PWA 
required measurements of peripheral oscillatory SBP and DBP at the brachial sites. These 
blood pressure values were recorded at the timepoints PRE-SIT in both the SHORT and LONG 
conditions, POST-SIT in the LONG condition, and 0-MS in both the SHORT and LONG 
conditions.  
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Mechanistic Outcomes: Autonomic Function  
 
LabChart and a PowerLab (ADInstruments) data acquisition system received analog 
data from all experimental devices. The software package utilized the electrocardiogram (EKG) 
signals to calculate heart rate variability (HRV), or the RR interval generated between two 
heartbeats. Five-minute intervals of this data were selected and averaged by the investigators at 
all seven time points in the SHORT condition (PRE-MS, 0-MS, 5-MS, 10-MS, 15-MS, 20-MS, 
and 30-MS) and all eight time points in the LONG condition (PRE-SIT, POST-SIT/PRE-MS, 0-
MS, 5-MS, 10-MS, 15-MS, 20-MS, and 30-MS).  
 
Mechanistic Outcomes: Calf Circumference 
 
A researcher measured the muscle belly thickness of the calf at the initiation and 
completion of the sitting period during each experimental condition to non-invasively observe 
potential blood pooling due to prolonged sitting. The leg chosen for this outcome was the leg not 
used for measures of arterial stiffness via the VICORDER device and its blood pressure cuffs. 
The investigator palpated the thickest portion of the muscle belly and recorded the distance 
from the medial malleolus for the first experimental condition. This distance was used during the 
second experimental condition to measure calf circumference from approximately the same 
latitude. At this latitude, the investigator used a Gulick tape measurer to record calf 
circumference 
 
Mechanistic Outcomes: Free-Living Activity 
 
Accelerometry was utilized to assess free-living physical activity beyond the 
experimental conditions. An wGT3X-BT ActiGraph was used to record raw counts of activity for 
translation into four classifications of activity bouts: sedentary, light, moderate, and vigorous. 
The Freedson 1998 algorithm for adults was used to translate counts into these classifications. 
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Activity during experimental conditions was also monitored to ensure participants were inactive 




Randomization software provided by a public website (www.randomizer.org) was be 
used to assign subjects either to the group completing SHORT or LONG first. This software was 
also used to randomize the placement of all VICORDER® cuffs on either the left or right side of 
the body. For the MAT, the subtraction of either seven or 13 for the first experimental condition 
was randomized. The second subtraction number was used for the second experimental 
condition. Due to the nature of the experiment, it is impossible to blind the participant and 




Calculations to determine the minimum sample size was based on the primary  
central vascular health outcome, aortic pulse wave velocity (PWV). The power calculation was 
based on reported normal values for the primary outcome, central PWV. Healthy people aged 
40-49 maintain an average PWV of 7.5 m/s72. For the current study, we opted to sample based 
on a conservative change score of 1 m/s. We also used a conservative usual error of 1.25 m/s 
based on reported data72. Magnitude-based inference was used to estimate the sample size 
required to detect the smallest detrimental (or beneficial) effect in a cross-over study, with the 
maximum chances of a type 1 and 2 error set at 5% (i.e. very unlikely). Approximately eighteen 









For a given outcome, all measurements and analyses were to be conducted by a single 
observer. Statistical outputs were observed for quality by an additional member of the research 
team to ensure data quality and proper analysis. 
 
DATA MANAGEMENT AND STATISTICAL ANALYSIS 
 
Data management and analysis were completed using several software packages. 
Storage and aggregation of experimental data were completed in Microsoft Excel (Excel, IN., 
Redmond, WA, USA). Heart rate variability analysis was conducted using Kubios HRV Standard 
Edition v3.3.1. Outcomes derived from HRV were log-transformed account for non-standard 
distribution. A dependent t-test was conducted on measures of arterial stiffness, pulse wave 
analysis, and heart rate variability between the timepoints of PRE-SIT and POST-SIT in the 
LONG condition. Mixed model analyses were performed in Jamovi v0.9 to observe the 
cardiovascular response to a mental stressor. Models for arterial stiffness were adjusted for site 
of measurement (bfPWV, cfPWV, or faPWV), experimental condition, and experimental time 
point. Models for outcomes from PWA and HRV were adjusted for condition and timepoint. 
Mean arterial pressure was a set as a covariate for all mixed models. Changes in outcomes are 
expressed relative to the values recorded at the PRE-MS/POST-SIT experimental time point. 
Data files and subjects were depersonalized with the suffix SMS (e.g. Participant 1 = SMS01, 2 
= SMS02, etc.). The α-level was set a priori for all statistical procedures at α=0.05. Effect sizes 
were calculated using Cohen’s d, where <0.20 is considered to be a small, > 0.20 to < 0.50 a 












Participant characteristics are summarized in Table 5. Ten participants were recruited, 
but four dropped out due to various reasons (see Figure 3). Participants self-identified as 
Caucasian (n=5) and African American (n=1).  
 


















Participants who did 
not respond or were 
not interested 
(n=133)










 Six participants (42.8 [7.7] y, 33% F, 24.8 [1.4] kg/m2) were successfully analyzed. 
There were no significant differences in anthropometric measures based on biological sex. 
TABLE 5. Participant characteristics (n=6). 
˚C, Celsius; mmHg, millimeters of mercury; cm, centimeter; kg/m2, kilograms per meter 
squared; min/wk, minutes per week; SD, standard deviation 
 
Control Data: Accelerometry 
 
Measurements of free-living activity before arrival for experimental sessions confirmed 
participants were sufficiently inactive. Accelerometry tracked the sample group in sedentary or 
light activity for 82.86% of wear time. Accelerometry data also showed participants were 
objectively sedentary during experimental conditions (LONG: 98.86% sedentary; SHORT: 
98.86% sedentary). Full accelerometry results are provided in Table 5.  
 
  All     Male   Female     
Variable n Mean (SD)   n Mean (SD)   n Mean (SD)   p 
Ambiance                     
Temperature, 
˚C 5 22.4 (0.55) 
 3 22.0 (0.00)  2 23.0 (0.00)  0 
Humidity, % 5 31.6 (15.60)   34.3 (18.1)  2 27.5 (16.3)  0.698 
Barometry, 
mmHg 4 753 (9.18) 
 3 756 (1.41)  2 751 (14.8)  0.654 
Participants           
Age, years 6 42.8 (7.70)  4 41.5 (9.15)  2 45.5 (4.95)  0.608 
Height, cm 6 169 (8.06)  4 173 (6.30)  2 161.0 (2.12)  0.063 
Weight, kg 6 71.5 (10.10) 4 76.3 (8.76)  2 61.9 (1.06)  0.093 
BMI, kg/m2 6 24.8 (1.36)  4 25.3 (1.44)  2 23.9 (0.22)  0.247 
Self-reported 
PA, min/wk 6 108 (55.60) 
 4 110.0 (70.7) 2 105.0 (21.2)  0.93 
Free-Living Activity         
% in Sedentary 6 39.2 (10.40) 
 4 34.5 (2.25)  2 48.5 (16.4)  0.129 
% in Light 6 43.7 (8.98)  4 48.3 (5.35)  2 34.5 (7.92)  0.059 
% in Moderate 6 17.1 (6.12)  4 17.2 (6.20)  2 17.1 (8.49)  0.987 




6 82.9 (6.12)  4 82.8 (6.20)  2 82.9 (8.49)  0.987 
% in MVPA 5 18.3 (5.98)  4 17.2 (6.20)  1 23.1  0.457 
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RESPONSE TO PROLONGED UNINTERRUPTED SITTING 
Calf Circumference 
 
Full results are displayed in Table 6 A nonsignificant time x condition interaction effect 
was observed (p=0.078, 95% CI: -1.050, 0.010). A significant main effect for time was observed 
(p<0.001, 95% CI: 0.575, 1.105) with values larger in the LONG condition compared to the 
SHORT condition.  
TABLE 6. Reported calf circumferences before and after sitting periods in the SHORT and 
LONG conditions. 
      Mean (SD)   p (ES) 
Outcome (n=6) PRE-SIT   POST-SIT   Time Interaction 
Calf 
Circumference, cm 
SHORT 35.9 (1.74)   36.4 (1.96)   <0.001 (0.904) 0.028 (0.475) 




See Figure 4 for visualization of changes in arterial stiffness. There were no significant 
differences observed between the PRE-SIT and POST-SIT timepoints for any measures of 
arterial stiffness. 
 
Oscillometric Blood Pressure 
 
There were no significant differences observed between the PRE-SIT and POST-SIT 
timepoints for any measures of oscillatory blood pressure (Table 7). 
TABLE 7. Response to two hours of prolonged sitting for measures of oscillatory blood 
pressure.  
      Mean (SD)   Significance 




SBP, mmHg   133.00 (12.10) 131.00 (9.28) 0.365   -0.29 
DBP, mmHg   78.30 (6.03) 77.70 (6.20) 0.749   -0.10 
 
bfPWV, brachial-femoral pulse wave velocity; m/s, meters per second; cfPWV, carotid-femoral 
pulse wave velocity; faPWV, femoral-ankle pulse wave velocity; SBP, systolic blood pressure; 
mmHg, millimeters of mercury; DBP, diastolic blood pressure; ES, effect size (Cohen’s d); PRE-




Pulse Wave Analysis 
 
All pre-post differences for measures of PWA were observed to be nonsignificant (Table 
8).  
TABLE 8. Response to two hours of prolonged sitting for measures of pulse wave analysis.  
      Mean (SD)   Significance 




HR, bpm   66.17 (7.98)   68.83 (10.84)   0.407   0.29 
SBP, mmHg   165.58 (21.06)   164.33 (15.78)   0.835   0.06 
  cSBP, mmHg   149.67 (21.68)   146.33 (13.82)   0.751   -0.10 
  AIx, %   10.67 (10.96)   12.25 (9.28)   0.659   0.13 
  SV, mL   241.00 (76.43)   245.00 (36.89)   0.522   0.20 
  CO, L/m   15.28 (3.21)   16.47 (1.49)   0.281   0.36 
  TPR, mmHg   0.19 (0.03)   0.17 (0.02)   0.244   -0.38 
HR, heart rate; bpm, beats per minute; AIx, augmentation index; L/m, liters per minute; CO, 
cardiac output; TPR, total peripheral resistance; SV, stroke volume; mL, milliliters 
 
Heart Rate Variability 
 
There were no significant differences observed between the PRE-SIT and POST-Sit 
timepoints for all measures of log-transformed HRV outcomes (Table 9). 
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TABLE 9. Response to two hours of uninterrupted prolonged sitting for measures of heart rate 
variability. 
      Mean (SD)   Significance 
Category Outcome (n=6)   PRE-SIT   POST-SIT   p   ES 
HRV Mean HR, bpm   66.67 (7.69)   68.60 (9.91)   0.122   -0.38 
  Min HR, bpm   60.17 (6.79)   62.50 (8.02)   0.118   0.67 
  Max HR, bpm   81.33 (14.05)   85.00 (13.22)   0.246   0.39 
  RMSSD, ms   25.13 (13.36)   18.73 (5.38)   0.351   -0.30 
 




FIGURE 4. Response to prolonged sitting for bfPWV (A), cfPWV (B), faPWV (C). Points 






























RESPONSE TO MENTAL STRESSOR: SHORT vs. LONG CONDITIONS 
 
Data collected immediately prior to the initiation of the MAT is designated as the PRE-
MS experimental time point. Due to the inherent structure of the LONG experimental condition, 
the POST-SIT timepoint equates to the PRE-MS timepoint in the context of this analysis.  
 
Mental Arithmetic Test Response: Visual Analog Scale 
 
There was no significant difference (p=0.495, ES=-0.39) between experimental conditions in 




There were no significant interaction effects observed over time for measures of arterial 
stiffness (Figure 5 and Figure 6). Main effects for time were nonsignificant for all measures of 
arterial stiffness. Main effects for experimental condition were significant with bfPWV smaller in 
the LONG condition (p<0.001, ES=-1.81) and faPWV was larger in the LONG condition 
(p=0.025, ES=0.59). Visualization of mental stress responses between conditions for each 
measure of arterial stiffness is shown in Figure 5 (bfPWV) and Figure 6 (cfPWV and faPWV). 
 
Oscillatory Blood Pressure 
 
Nonsignificant interaction effects were observed for oscillatory SBP (p=0.156, ES=0.68) 
and DBP (p=0.455, ES=0.33) (Table 10). A significant condition effect was observed in 
oscillatory DBP (p=0.002, ES=0.70) with values 2.6 mmHg higher in the LONG condition. Main 
effects for time were found to be nonsignificant for both measures of oscillatory blood pressure. 
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TABLE 10. Oscillatory blood pressure response to a mental stressor. 
X, average; PRE-MS, last timepoint before exposure to the mental stressor; 0-MS, immediately 
after the completion of the MS, 5-MS, five minutes post completion of the MS; 5=10-MS, ten 
minutes post completion of the MS; 15-MS, 15 minutes post completion of the MS; 20-MS, 20 
minutes post completion of the MS; 30-MS, 30 minutes post completion of the MS. 
  
      Oscillatory Blood Pressure   
      SBP   DBP   
      mmHg   mmHg   
X LONG PRE-SIT 133.00   78.30   
    POST-SIT/PRE-MS 131.00   77.70   
    0-MS 136.00   83.30   
    5-MS         
    10-MS         
    15-MS         
    20-MS         
    30-MS         
  SHORT PRE-MS 130.00   75.90   
    0-MS 137.00   79.50   
    5-MS         
    10-MS         
    15-MS         
    20-MS         
    30-MS         
SD LONG PRE-SIT 12.10   6.03   
    POST-SIT/PRE-MS 9.28   6.20   
    0-MS 8.39   7.37   
    5-MS         
    10-MS         
    15-MS         
    20-MS         
    30-MS         
  SHORT PRE-MS 10.60   6.25   
    0-MS 5.35   4.22   
    5-MS         
    10-MS         
    15-MS         
    20-MS         
    30-MS         
Interaction   p 0.059   0.199   
Time   p 0.595   0.192   
    ES -0.35   0.59   
Condition   p 0.799   0.002   
    ES 0.66   0.7   
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FIGURE 5. bfPWV response to mental stressor. Dots represent marginal means of 














Condition: p<0.001, ES=-1.81 
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FIGURE 6. Secondary (cfPWV, A; faPWV, B) outcome responses to standardized 
mental stressor. Points represent marginal means from mixed models.  
Pulse Wave Analysis 
 
Significant interaction effects were observed in cSBP, (p<0.001) and SV (p=0.016). 
Additionally, a significant main effect for condition was observed for cSBP (p<0.001, ES=-3.96). 
Values for this outcome were lower in the LONG condition. Nonsignificant interaction effects nor 














BInteraction: 0.653Time: p=0.232, ES=-0.22













AInteraction: 0.187Time: p=0.711, ES=-0.36Condition: p=0.648, ES=0.26 
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TABLE 11. Response to a mental stressor for measures of pulse wave analysis. 
     Pulse Wave Analysis                       
      HR  SBP  cSBP AIx  SV  CO  TPR   
      bpm   mmHg     %   mL   L/m       
X LONG PRE-SIT 66.17 165.58 149.67 20.20   241.00 15.28 0.19   
  POST-SIT/PRE-MS 68.83 164.3 146.33 20.17   245.00 16.47 0.17   
  0-MS 67.50 158.50 139.92   18.30   223.00 15.26 0.19   
  5-MS 67.42 160.92 143.75   14.20   218.80 15.56 0.18   
  10-MS 67.33 159.08 140.25   16.40   211.10 14.35 0.20   
  15-MS 69.75 159.67 140.92   15.10   221.90 15.15 0.19   
  20-MS 69.50 168.60 150.40   14.90   224.25 15.77 0.18   
  30-MS 67.50 165.33 146.83   14.90   240.17 16.29 0.18   
SHORT PRE-MS 69.33 166.25 148.25   17.30   204.30 14.11 0.21   
  0-MS 68.00 169.83 152.33   17.50   224.38 15.89 0.19   
  5-MS 67.50 169.17 151.17   17.80   222.40 15.59 0.19   
  10-MS 69.33 172.17 154.83   15.50   230.70 15.88 0.19   
  15-MS 68.58 175.17 157.58   18.50   224.42 16.10 0.19   
  20-MS 68.58 171.83 153.75   17.50   234.63 16.81 0.17   
  30-MS 70.00 164.92 149.92   13.50   212.00 15.65 0.20   
SD LONG PRE-SIT 7.98   21.06   21.68   10.96   76.43   3.21   0.03   
  POST-SIT/PRE-MS 10.84 15.78   13.82   9.28   36.89   1.49   0.02   
  0-MS 6.24   6.87   9.84   10.23   17.06   1.74   0.03   
  5-MS 6.13   9.99   11.48   7.35   21.28   1.24   0.02   
  10-MS 1.89   6.06   12.68   10.37   49.02   3.06   0.04   
  15-MS 5.46   6.58   7.36   7.27   27.90   2.22   0.04   
  20-MS 7.51   12.95   12.45   8.99   37.64   1.45   0.03   
  30-MS 5.89   10.56   10.60   10.22   20.33   1.29   0.03   
SHORT PRE-MS 9.51   18.73   13.81   10.41   17.01   1.14   0.04   
    0-MS 5.67   9.60   8.72   8.34   21.78   2.12   0.02   
    5-MS 5.19   9.50   8.51   9.17   19.28   1.43   0.02   
  10-MS 6.11   13.21   13.44   7.80   27.46   1.69   0.02   
  15-MS 6.78   13.25   11.32   8.74   21.94   1.69   0.04   
  20-MS 8.06   16.43   14.69   9.62   35.15   1.20   0.03   
  30-MS 10.12   13.34   11.82   6.62   30.07   2.77   0.03   
Interaction p 0.838 0.002   <0.001 0.264   0.016   0.060   0.041   
Time 
  p 
0.777 
  0.412   0.149   0.227   0.742   0.541   0.296   
    ES -0.29   -0.34   -0.45   -0.67   -0.33   -0.46   0.44   
Condition 
  p 0.462 <0.001 <0.001   <0.001   0.505   0.323   0.037   




Heart Rate Variability 
 
Non-significant interaction effects and main effects for time and condition were observed for 
computed measures of HRV: mean HR, min HR, max HR, and RMSSD (Table 12).  
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TABLE 12. Response to a mental stressor for measures of heart rate variability. 
      Heart Rate Variability           
      Mean HR   Min HR   Max HR   RMSSD   
      bpm   bpm   bpm   ms   
X LONG PRE-SIT 66.67   60.17   81.33   25.13   
    POST-SIT/PRE-MS 68.60   62.50   85.00   18.73   
    0-MS 69.83   57.83   91.17   32.40   
    5-MS 70.50   63.17   86.83   24.47   
    10-MS 58.83   50.00   97.33   65.90   
    15-MS 65.33   55.17   87.50   61.92   
    20-MS 69.40   56.60   84.00   31.66   
    30-MS 67.00   51.50   88.50   54.97   
  SHORT PRE-MS 70.67   57.67   91.83   34.38   
    0-MS 70.67   50.17   92.67   74.98   
    5-MS 70.33   58.00   89.83   39.53   
    10-MS 70.00   57.33   97.33   65.82   
    15-MS 69.33   53.83   91.67   52.98   
    20-MS 68.50   52.17   85.17   49.17   
    30-MS 72.00   60.83   89.17   40.95   
SD LONG PRE-SIT 7.69   6.79   14.05   13.36   
    POST-SIT/PRE-MS 9.91   8.02   13.22   5.38   
    0-MS 7.08   15.96   10.59   33.10   
    5-MS 5.39   5.78   7.57   11.90   
    10-MS 27.62   19.04   15.93   69.33   
    15-MS 10.75   18.44   15.06   94.61   
    20-MS 6.80   11.52   9.70   27.73   
    30-MS 6.42   15.20   13.90   56.02   
  SHORT PRE-MS 8.31   16.87   14.50   29.68   
    0-MS 6.44   19.57   8.76   65.01   
    5-MS 7.74   18.92   5.31   46.29   
    10-MS 5.97   19.64   32.59   94.27   
    15-MS 7.31   19.97   13.22   63.36   
    20-MS 9.31   22.77   5.19   50.70   
    30-MS 8.29   17.23   5.00   35.68   
Interaction p 0.163   0.176   0.947   0.325   
Time p 0.931   0.876   0.474   0.577   
    ES -0.33   -0.30   0.35   0.42   
Condition p 0.093   0.287   0.248   0.251   








CHAPTER V: DISCUSSION 
 
The purpose of this study was to investigate the cardiovascular response to mental 
stress: (i) with and (ii) without previous exposure to prolonged sitting in the middle-aged white-
collar worker population. (i) Two hours of prolonged sitting, without mental stress, had no effect 
on any arterial stiffness outcome. (ii) Two hours of prolonged sitting, without mental stress, led 
to increased (worsened) peripheral arterial stiffness but decreased (improved) central arterial 
stiffness. The opposing arterial stiffness responses indicate a complex cardiovascular response 
to mental stress combined with prolonged sitting.  
 
LIMITATIONS AND STRENGTHS 
 
The limitations and strengths of this study should be addressed to its findings. First, due 
to the COVID-19 pandemic, investigators were unable to recruit a sample size to achieve 
adequate statistical power. The underpowered nature of these results inherently weakens the 
plausibility of drawn conclusions. A second limitation was the potential influence of testing in the 
seated upright position on the reliability of PWV and PWA assessment. Indeed, these arterial 
stiffness measures have been demonstrated to be experimentally valid and reliable, but only in 
a supine position73–75. Data published from this research group indicates PWV measures may 
be unreliable in a seated position76. Investigators chose this position for the protocol in an effort 
to reduce time commitments for participants. Also, sudden changes between the supine and 
seated position are known to significantly change whole-body hemodynamics and more time 
would be required to accurately test cardiovascular function77–79. Third, is the potential learning 
effect to the MAT participants may have experienced between conditions. Investigators 
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incorporated randomization procedures to minimize this influence, but responses to the MAT 
within participants may have been significantly altered between conditions. 
 Despite these weaknesses, several design aspects strengthened internal validity. One 
strength was the investigators’ ability to time-match experimental conditions within subjects. 
Alertness varies throughout the time of day, and this standardization prevented the influence of 
activities of daily living on collected data. A second strength is the homogeneity of the six 
participants. All individuals were similarly aged, inactive, and free of preexisting cardiometabolic 
disorders. Finally, primary components of the study design, the duration of prolonged sitting and 
the MAT as the mental stressor, are research standards. Previous research has reported that 
two hours of sitting impaired cardiovascular outcomes,22,23,80 and the MAT is frequently used 
cardiovascular stressor81–83.  
 
COMPARISON TO LITERATURE 
Response to Prolonged Sitting 
 
Two hours of prolonged had a non-significant effect on all arterial stiffness measures. 
This lack of change is contradictory to the study’s hypotheses and established literature. Pulse 
wave velocity is an established measure of arterial stiffness, with acute changes hypothesized 
to occur due to endothelial dysfunction15,45. Restaino et al. propose endothelial dysfunction due 
to prolonged sitting is caused by a reduction in shear stress, a mechanistic precursor that 
stimulates vasodilation50. As shown in our proposed mechanism (Figure 1), disruptions to 
peripheral cardiovascular function impact arterial stiffness and subsequently, the heart 42. A 
three-hour sitting study observed a 0.4 m/s increase in central PWV and a significant decrease 
in endothelial function. Collectively, these studies of similar design indicate measures of 
endothelial function and arterial stiffness are significantly worsened after exposure to prolonged 
sitting. A lack of change observed in this experiment may be due to the poor experimental 
reliability of PWV in the seated position. This position was chosen to minimize body movement 
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and its known influence on resting hemodynamics. A recent study by Kowalsky et al. studied the 
reliability of central PWV measures, specifically carotid-radial PWV and carotid-ankle PWV and 
found outcomes to be unreliable in a seated posture84. Conversely, Nürnberger et al. found 
supine and seated values of cfPWV in good agreement through a Pearson’s correlation 
coefficient85.  A lack of consensus indicates further research is needed on body position’s 
influence on measures of arterial stiffness.  
All changes after exposure to prolonged sitting in PWA outcomes were nonsignificant. 
Augmentation index, expressed as a percentage, has been shown to significantly decrease by 8 
percentage points in response to prolonged sitting42. Our reported data shows a non-significant 
increase by 1.58 percentage points. Nonsignificant differences in central and peripheral systolic 
blood pressure and peripheral diastolic blood pressure, however, agree with established 
literature. Vranish et al., along with additional studies23,42 observed non-significant in these 
outcomes86. Non-significant findings may be due to an underpowered sample size. Our power 
analysis indicated a sample size of 18 would be sufficient for adequate power. The revised 
experimental timeline due to the emergence of the COVID-19 pandemic prevented investigators 
from recruiting an appropriately sized sample. Recruitment of a sample size that fulfills the 
power analysis should be completed before conclusive discussion can be made. 
 
Response to Mental Stress 
  
It was hypothesized that increases in arterial stiffness due to mental stress would be 
significantly higher after exposure to prolonged sitting. Peripheral arterial stiffness was 
significantly higher in the LONG condition (p=0.025, ES=0.59) with a medium effect. This finding 
aligns with our stated hypothesis and previous studies observing increases in arterial stiffness 
due to prolonged sitting24,42 and mental stress87,88. Though these increases were expected, they 
only were observed between experimental conditions and not over time after exposure to the 
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MAT. The lack of a time effect may be due to an inadequate stress response to the MAT. 
Studies using this test observed 7-12 mmHg increases in central and peripheral SBP, 7-20 bpm 
increases in HR, and 0.29-0.57 m/s increases in PWV18,58,62,87 from resting values. The condition 
effect may be attributable to blood pooling int the lower extremities (Figure 1). The autonomic 
nervous system theoretically responds to increased blood volume in the lower limbs with 
vasoconstriction to maintain venous return89. A lack of change in stroke volume and cardiac 
output between conditions and amongst experimental timepoints suggests this response was 
activated. There were no significant changes in our HRV outcomes; however, these measures 
only assessed parasympathetic activity. A limitation of this study was its inability to more directly 
assess sympathetic activation. Our usage of heart rate measures (mean, minimum, and 
maximum) and blood pressure were methods of sympathetic monitoring, but more robust tests 
like the assessment of circulating catecholamine levels are available79,90. Our unexpected 
results may have significant implications for future research on physiological responses to 
behavioral and psychological stressors. Future studies should incorporate comprehensive 
neurological and cardiovascular monitoring to testing protocols to observe underlying 
interactions between sedentary behaviors and mental stress.  
The primary outcome of this study, bfPWV, was significantly lower after exposure to the 
MAT in LONG compared to the SHORT condition (p<0.001, ES=-1.81). Not only is the 
directionality against expectations, but the magnitude of reduction between conditions, 1.4 m/s, 
far surpasses changes in arterial stiffness found in previous literature. To contextualize these 
changes, in a systematic review by Vlachopolos et al., a 1.0 m/s increase in central PWV 
translates to a 15% increased risk for CVD’s91. This group also studied changes in PWV due to 
psychological stress and observed an increase in only 0.29 m/s87. Also, in contrast, a secondary 
outcome, cfPWV, a measure of central arterial stiffness, did not change regardless of 
experimental timepoint or condition. As previously discussed, these unusual cardiovascular 
responses may simply be the result of unreliable data and an insufficient sample size. However, 
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significant changes in mechanistic outcomes suggest a physiological explanation. Our 
understanding of the physiological response to prolonged sitting50,51,92 and mental stress16,21,93 is 
relatively new and our results are both aligned and starkly in contrast with previous findings. 
Early postural research like that completed by Shvartz et al., outlined compensatory 
cardiovascular responses to sitting and blood pooling in the peripheral vasculature. In this study, 
in the first hour of sitting, calf blood volume increased by 17% with blood pressure and total 
peripheral resistance increasing in response to these changes. Mental stressors also acutely 
impact cardiovascular function with studies like Åhlund et al. and Lipman et al. observing 12.8 
mmHg and 15.7 mmHg increases in blood pressure outcomes18,82. Our reported non-invasive 
calf circumference data aligns with foundational blood pooling research from Shvartz et al. 
showing a significant swelling of the lower limbs with larger values in the LONG condition. 
However, our data diverges from previous research as seen with peripheral systolic blood 
pressure 8 mmHg lower in the LONG condition (Interaction: p=0.002) and central systolic blood 
pressure was 9 mmHg lower (Interaction: p<0.001). It may be hypothesized that increased 
blood volume in the lower periphery due to prolonged sitting inhibits increases in central pulse 
wave velocity. The imbalance in blood volume due to gravity may significantly impair central 
hemodynamics and the ability to react to psychological stressors. The influence of changes in 





Changes in cardiovascular outcomes in response to behavioral and psychological stressors are 
understood in isolation. Vranish et al., for example, observed significant disruptions to lower limb blood 
flow and shear stress after only ten minutes of sitting. Acute exposure to prolonged sitting has also been 
shown to increase blood viscosity94, impair endothelial function86, and decrease markers of cardiac 
function14,24. The acute disruptions to markers of central and peripheral cardiovascular health due to 
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mental stress are also well defined18,58,62. What is less understood is how these stressors interact, in this 
case, how prolonged sitting influences the cardiovascular response to a standardized mental stressor. In 
their workspace, the average American worker not only is excessively sitting, but experiences near-
constant exposure to high levels of mental stress95. According to the 2018 Physical Activity Guidelines for 
Americans, guidelines on reducing sedentary behaviors are not presently possible because research on 
this topic is inadequate29. If research-based guidelines are to be established, our understanding of 
prolonged sitting must be expanded beyond the laboratory setting. Our physiological models detailing a 
sedentary behavior’s effect on cardiovascular health must incorporate other stressors. To our knowledge, 
no study has attempted to research the acute cardiovascular disruptions due to prolonged sitting and 
mental stress in combination. This study, fortunately, provides preliminary data on this gap in knowledge. 
Unexpectedly, we observed opposing directionality between the changes of our arterial stiffness 
measures: bfPWV was 1.4 m/s lower and faPWV was 1.86 m/s higher in the LONG condition with 
exposure to prolonged sitting before the MAT. The magnitude of these changes in response to combined 
stressors also far surpass studies observing changes to stressors in isolation. Further investigation into 
this potential interaction effect and the autonomic and hormonal response to sedentary behaviors and 
psychological stress is recommended. Continued physiological research on these response pathways will 





In conclusion, preliminary data has revealed the cardiovascular response to a mental 
stressor may be significantly disrupted with previous exposure to prolonged sitting. Increases in 
peripheral arterial stiffness were aligned with previous research, however, central arterial 
stiffness was improved with significant decreases. These contrasting directions between 
peripheral and central arterial stiffness outcomes indicate behavioral and physiological stressors 
may influence one another when affecting the cardiovascular system. Further study on the 
impact of changes in peripheral outcomes on central cardiovascular outcomes is warranted as 
well as the potential dependence outcomes of arterial stiffness may have on body position. 
Definitive conclusions on these physiological and methodological implications of this study 
should be explored when recruitment and testing are completed.  
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Department of Exercise and Sport Science 
Medical History Questionnaire Screening 
 
Subject:__________________________   
Cell Phone #:______________ 
 
Patient History           
        YES NO 
1. Do you have any health problems at the present time?  _____ _____ 
2. If yes, please describe:         
            
3. Have you ever been told you have heart trouble?   _____ _____ 
4. If yes, please describe:         
            
5. Do you ever get pain in your chest?     _____ _____ 
6. Do you ever feel light-headed or have you ever fainted?  _____ _____ 
7. If yes, please describe:         
            
8. Have you ever been told that you have high blood pressure?  _____ _____ 
9. If yes, please describe:         
            
10. Have you ever had difficulty breathing at rest or with exertion? _____ _____ 
11. If yes, please describe:         
            
12. Have you ever been treated for infectious mononucleosis, hepatitis, pneumonia, 
or another infectious disease during the past year?    _____ _____ 
13. If yes, name the disease:         
14. Have you ever been treated for or told you might have diabetes? _____ _____  
15. Have you ever been treated for low blood sugar?   _____ _____ 
16. Have you ever experienced heat stroke or heat exhaustion?  _____ _____ 
17. If yes, when?           
            
18. Are you now taking any pills, medications, or supplements?  _____ _____ 
19. If yes, please list:          
            
20. Have you had any recent (within 1 year) difficulties with your: 
 a.  Feet         _____ _____ 
 b.  Legs         _____ _____ 
 c.  Back         _____ _____ 
Menstrual Cycle 
21. What was the start date of your most recent menstrual cycle? __________ 
Family History 
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22. Has anyone in your family (grandparent, father, mother, and/or sibling) 
experienced any of the following? 
 a.  Sudden death       _____ _____ 
 b.  Cardiac disease       _____ _____ 
 c.  Marfan’s syndrome      _____ _____ 
 
Activity History 
23. During your early childhood (to age 12) would you say you were: 
 Very active ____ Quite active____ Moderately active____ Seldom active____ 
24. During your adolescent years (age 13-18) would you say you were: 
 Very active ____ Quite active____ Moderately active____ Seldom active____ 
25. Did you participate in: 
a. Intramural high school sports?     _____ _____ 
b. Community sponsored sports?     _____ _____ 
c. Varsity high school sports?     _____ _____ 
d. Active family recreation?      _____ _____ 
26. Since leaving high school, how active have you been? 
 Very active ____ Quite active____  Active____  Inactive____ 
27. Have you previous participated in strength training   _____ _____ 
28. Do you participate in any moderate to vigorous activity at present? _____ _____ 
29. If yes, please list: 
Activity  Frequency   Duration  Intensity 
             
             
             
          
30. Whom shall we notify in case of emergency? 
 Name:            
 Phone: (Home)     (Work)     
 
Signature:        Date:     
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APPENDIX B: INFORMED CONSENT 
University of North Carolina at Chapel Hill 
Consent to Participate in a Research Study 
Adult Participants  
 
Consent Form Version Date: 12/05/19 
IRB Study # 19-1843 
Title of Study: The Combined Effects of Prolonged Sitting and Mental Stress on Vascular and 
Cerebrovascular Function in Middle-Aged Adults 
Principal Investigator: Blackwell, Jade 
Principal Investigator Department: Exercise and Sport Science 
Principal Investigator Phone number: (919) 962-0396 
Principal Investigator Email Address: jb95@live.unc.edu  
Faculty Advisor: Lee Stoner 





We are looking to examine the vascular, cerebrovascular response to mental stress with or 
without prior exposure to prolonged sitting while also observing executive function. It is currently 
unknown whether (1) prolonged sitting and mental stress have systemic vascular health effects 
(2) whether sitting and mental stress impairs blood flow to the brain and perfusion of the 
prefrontal cortex (3) how mental stress affects vascular function and cerebrovascular function, 
and (4) what specific mechanisms explain these changes. The devices used in this study are 
non-invasive and no known adverse events have occurred with use of the stated devices. The 
findings from this study may result in a public health message regarding sedentary behaviour 
and stress, and will help elucidate the mechanisms behind acute vascular, cerebrovascular, and 
cognitive dysfunction during prolonged sitting. 
  
What are some general things you should know about research studies? 
You are being asked to take part in a research study.  To join the study is voluntary. 
You may choose not to participate, or you may withdraw your consent to be in the study, for any 
reason, without penalty. 
 
Research studies are designed to obtain new knowledge. This new information may help people 
in the future.   You may not receive any direct benefit from being in the research study. There 
also may be risks to being in research studies. Deciding not to be in the study or leaving the 
study before it is done will not affect your relationship with the researcher, your health care 
provider, or the University of North Carolina-Chapel Hill. If you are a patient with an illness, you 
do not have to be in the research study in order to receive health care. 
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Details about this study are discussed below.  It is important that you understand this 
information so that you can make an informed choice about being in this research study.  
 
You will be given a copy of this consent form.  You should ask the researchers named above, or 
staff members who may assist them, any questions you have about this study at any time. 
 
What is the purpose of this study? 
The purpose of this research study is to (1)  Explore the cardiovascular effects of mental stress 
with and without a bout of prolonged sitting on cerebrovascular function, and (2) Explore the 
effects of mental stress with and without a bout of prolonged sitting on vascular function. 
 
Are there any reasons you should not be in this study? 
You should not be in this study if you have known cardiovascular or metabolic diseases (e.g. 
Congestive heart failure, peripheral artery disease, type I and II diabetes, etc.), you smoke 
tobacco, take medications known to affect cardiovascular function (e.g. beta-blockers, ACE 
inhibitors) or you are pregnant. 
 
How many people will take part in this study? 
There will be approximately 20 people in this research study. 
 
How long will your part in this study last? 
Should you wish to participate in the study, you will be required to attend the Applied Physiology 
Laboratory at University of North Carolina at Chapel Hill on three occasions. The first visit will 
last approximately 35 minutes, the CON visit lasts approximately 60 minutes and the SMS 
approximately 160 minutes. 
 
What will happen if you take part in the study? 
If you would like to take part in the study, you would be required to visit the Applied Physiology 
Laboratory at UNC, Chapel Hill on three occasions. See below for overall study design: 
Visit 1 - The first visit will be a familiarization session during which all experimental procedures 
will be described to you in full. You will provide informed consent before the study begins, then 
complete a brief questionnaire on your medical history to ensure you are eligible for this study. If 
you meet the requirements, we will then show you how each device is prepared for this study, 
how it functions and where it will be placed on the body for data collection. No data will be 
collected during this session for further analysis. The following devices will be used for study 
purposes:  
• Transcranial Doppler (TCD) – A headset snugly placed on top of the head 
• VICORDER® – Non-invasive device using blood pressure cuffs to assess arterial 
health 
• Ultrasound Probe – Small probe lightly placed over several arteries running up 
the neck to assess blood flow to the brain 
• Near-Infrared Spectroscopy (NIRS) – Small probe (about 1 x 3 inches in size) 
placed on the forehead 
• Non-invasive Blood Pressure cuff (NIBP)– Device wrapped around the wrist with 
small cuffs encircling the middle and index fingers 
This visit should take approximately 35 minutes. 
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Visit 2 & 3 - During the experimental visits (CON and SMS), you will be required to rest quietly 
for a period of 10 minutes in a supine (lying) position, During the CON visit, you will undergo a 
brief 20min sitting period. Measures of cardiovascular function will be taken by the VICORDER® 
and Ultrasound devices. For the SMS condition, you will be asked to sit still and quietly for two 
hours while watching a non-stimulating documentary. Measures of cardiovascular function will 
be taken by the VICORDER® and Ultrasound devices at the beginning and 10 minute before 
the cessation of the sitting period. At the end of the sitting period in each experimental condition 
we will then conduct a Mental Arithmetic Test (MAT). Data collections procedures will be 
completed again for the VICORDER® and Ultrasound devices. Finally, a battery of cognitive will 
be conducted after data collection is complete.  
Prior to attending the Lab for visits 2 & 3, you will have to perform the following pre-assessment 
guidelines: 
• Fasted (> 12 hours), consuming only water. 
• No caffeine consumption 12 hours prior to testing 
• No vigorous exercise 24 hours prior to testing. 
• No alcohol consumption 24 hours prior to testing. 
Pregnancy tests will be done on all females who might be able to get pregnant at the start of the 
study. The research team will pay for these pregnancy tests.  
The total time commitment that will be required from you is approximately 265 minutes. 
Following the analysis of your data, we will happily provide a summary of your results in 
comparison to the group means. 
What are the possible benefits from being in this study? 
There is no direct benefit to participation. 
 
What are the possible risks or discomforts involved from being in this study?  
The data generated from this study will be used for the purpose of scholarly publication and 
potentially for research presentation. Your personal data will not be identifiable. However, there 
is an inherent risk for a breach of confidentiality due to the sharing of personal information with 
the research team for research purposes.  
Breach of confidentiality will be minimized by limiting the number of research team members in 
the laboratory during any testing session. By needing key card access to the laboratory, we are 
limiting the number of individuals not on the research team who have access to the lab. Those 
who do have key card access are exercise physiology professors, PhD candidates, and 
master’s candidates, and selected undergraduate students who are directly associated with the 
study and have performed all necessary trainings regarding sample handling, laboratory 
procedures, and confidentiality. All participants within the study are coded with an individual ID 
and no names will be identified in any document besides a master key document. This master 
key document will be kept in a locked drawer in the Cardiometabolic Laboratory within the 
Applied Physiology Laboratory. 
The devices used in this study are non-invasive and there are no accounts of severe injury due 
to exposure to the stated devices. Physical harm due to participation in this study is likely very 
minimal: 
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VICORDER® - The system requires the placement of pressure cuffs over several arteries for 
the collection of PWV/A data. Pressure cuffs will only be inflated underneath a level of 65 
mmHg. Physical harm or discomfort is unlikely and include, but are not limited to: 
Risk 1: Discomfort/unease: Infrequent (1 – 10%) – Application of a slight pressure over the 
carotid artery may impose a sense of unease for the participant. However, the light pressure 
used for this experimental protocol will in no way significantly damage cardiovascular structure 
or place the participant in danger. Investigators will make certain that communication on the 
procedures during testing session are clearly conveyed to the participant for comfort and 
safety.  
Near-infrared spectroscopy (NIRS): Risk of injury or discomfort is extremely low due to this 
device. Possible physical harms are, but not limited to: 
Risk 1: Eye damage/irritation: Rare (<1%) – Please do not, at any point, stare into the light 
emitted from the NIRS probe 
Risk 2: Skin heating and irritation: Rare (<1%) – Wearing the NIRS probe for extended periods 
of time at once can theoretically lead to a warm feeling at the area where the probe is placed. 
However, this risk is minimal because the light emitted from this probe is not powerful enough to 
heat the skin. If you let the investigators know of any discomfort due to the probe, we will follow 
manufacturer guidelines to ensure the device is functioning correctly. 
Transcranial Doppler (TCD): Data collection from this system requires the affixation of a 
headpiece to the participant. Risk of injury due to this device is extremely low. Possible harms 
may include, but are not limited to: 
Risk 1: Mild headache: Infrequent (1 – 10%)  – High quality data from this device requires the 
placement of the probe over the middle cerebral artery (MCA) and posterior cerebral artery 
(PCA). The slight pressure applied to the area may be slightly discomforting and unusual for the 
participant. 
 
What if we learn about new findings or information during the study?  
You will be given any new information gained during the course of the study that might affect 
your willingness to continue your participation.  
 
How will information about you be protected? 
Hard copies of any identifiable information will be stored in a locked file cabinet within an 
access-controlled laboratory in Fetzer Hall (Applied Physiology Lab) at the University of North 
Carolina at Chapel Hill campus. Only members of the research team will have access to the 
cabinet. Any electronic files with identifiable information will be kept separate in password 
protected files on password protected computers that will be accessible to only members of the 
research team. Upon completion of the study, all data will be transferred to an electronic storage 
device, files will become password protected, and all hard copies will be shredded. 
Participants will not be identified in any report or publication about this study.  We may use de-
identified data and/or specimens from this study in future research without additional consent. 
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Although every effort will be made to keep research records private, there may be times when 
federal or state law requires the disclosure of such records, including personal information.  This 
is very unlikely, but if disclosure is ever required, UNC-Chapel Hill will take steps allowable by 
law to protect the privacy of personal information.  In some cases, your information in this 
research study could be reviewed by representatives of the University, research sponsors, or 
government agencies (for example, the FDA) for purposes such as quality control or safety. 
What will happen if you are injured by this research? 
All research involves a chance that something bad might happen to you.  If you are hurt, 
become sick, or develop a reaction from something that was done as part of this study, the 
researcher will help you get medical care, but the University of North Carolina at Chapel Hill has 
not set aside funds to pay you for any such injuries, illnesses or reactions, or for the related 
medical care.   
The Sponsor of the study, Dr. Lee Stoner, has agreed to pay all reasonable medical expenses 
for the treatment of reactions, illnesses or injuries related to the use of the study drug/device, 
defects in the manufacture of the study drug/device, or as a direct result of properly performed 
study tests and/or procedures, except to the extent such expenses are due to the negligence of 
the study staff or due to your current disease or condition unless it is made worse because you 
are taking part in this study. 
The Sponsor has not set aside funds to pay for lost wages or any other losses or expenses.  
Any costs for medical expenses not paid by the Sponsor will be billed to you or your insurance 
company.  You may be responsible for any co-payments and your insurance may not cover the 
costs of study related injuries.   
If you think you have been injured from taking part in this study, call Jade Blackwell. She will let 
you know what you should do.   
By signing this form, you do not give up your right to seek payment or other rights if you are 
harmed as a result of being in this study. 
 
What if you want to stop before your part in the study is complete? 
You can withdraw from this study at any time, without penalty.  The investigators also have the 
right to stop your participation at any time. This could be because you have had an unexpected 
reaction, or have failed to follow instructions, or because the entire study has been stopped. 
 
Will you receive anything for being in this study? 
You will be compensated for your time. After each completed experimental session (Visit 2 & 3), 
you will receive a $50 Visa gift card. You will be compensated $100 in total for being in this 
study. 
 
Will it cost you anything to be in this study? 
It will not cost you anything to be in this study.  
 
What if you are a UNC student? 
You may choose not to be in the study or to stop being in the study before it is over at any 
time.  This will not affect your class standing or grades at UNC-Chapel Hill.  You will not be 
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offered or receive any special consideration if you take part in this research. 
 
What if you are a UNC employee? 
Taking part in this research is not a part of your University duties and refusing will not affect 
your job.  You will not be offered or receive any special job-related consideration if you take part 
in this research. 
 
What if you have questions about this study? 
You have the right to ask, and have answered, any questions you may have about this 
research. If you have questions about the study (including payments), complaints, concerns, or 
if a research-related injury occurs, you should contact the researchers listed on the first page of 
this form. 
 
What if you have questions about your rights as a research participant? 
All research on human volunteers is reviewed by a committee that works to protect your rights 
and welfare.  If you have questions or concerns about your rights as a research subject, or if 
you would like to obtain information or offer input, you may contact the Institutional Review 




I have read the information provided above.  I have asked all the questions I have at this time.  I 
voluntarily agree to participate in this research study. 
 
______________________________________________________ 

























APPENDIX C: REMINDERS PACKET  
 
The Cardiometabolic Laboratory (CML) would like to thank you for agreeing to participate in the 
research study entitled:  
 
The Combined Effects of Prolonged Sitting and Mental Stress on Vascular and Cerebrovascular 
Function in Middle-Aged Adults 
 
Please read these instructions in their entirety before the end of today! This packet we are 
providing you will provide all the necessary instructions to follow to ensure your participation in 
this study allows the research team to answer the questions we’re asking for this study.  
 
Purpose and Introduction to This Study 
 
We, Jade Blackwell and Jake Diana, are the primary investigators for this study for the 
completion of our master’s thesis under the guidance of Dr. Lee Stoner, Assistant Professor 
here at the University of North Carolina at Chapel Hill. 
 
Here at the Cardiometabolic Laboratory (CML) our research team studies the changes to the 
cardiovascular system in response to different behaviors and actions like prolonged sitting, 
mental stress, food consumption, and much more.  
 
The purpose of this study is to better understand how extended periods of sitting affect 
the internal cardiovascular response to a standardized mental arithmetic test.  
 
The Procedure of This Study 
 
You will only be required to come back to the CML for two additional visits:  
 
1. Control (CON) visit – Time commitment approximately 35 minutes 
2. Sitting-Mental Stress (SMS) visit. – Time commitment approximately 195 minutes 
 
We are requiring 20 middle-aged adults to complete this study in its entirety. Depending on 
which subject number you are, you will be required to complete the CON and SMS visit in a 
specific order: 
 
Your Subject ID is SMS 
 
You will complete the _______ visit first, then the ________ visit 
 
 
Procedure of the Study 
 
I. Pre-Assessment Guidelines 
 
Definition: Actions or behavioral restrictions that must be followed before we begin an 
experimental visit (CON and SMS): 
 
• 12 hour fasting, consuming only water 
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• No caffeine consumption 12 hours prior to testing 
• No vigorous exercise 24 hours prior to testing (sprinting, prolonged resistance 
training, powerlifting, etc.) 
• No alcohol consumption 24 hours prior to testing 
• Awaken at the same time on both experimental visit times  
• Please wear for the experimental visits 
o Loose-fitting, athletic clothes for your comfort 
o Short sleeve shirt and shorts for easy device attachment 
o Short socks so we can see your ankle for measurements 
• If you have long hair, please wear up or in a ponytail 
 
We ask that you follow these guidelines to ensure the data collected is not affected by other 
external influences. 
 
II. Time-Matching the Mental Arithmetic (MAT) 
 
The information we collect after the mental arithmetic test (MAT) is very important for the 
purpose of this study. If we want to compare data from one experimental visit to the other, we 
need to match when “on the clock” you take the MAT.  
III. Description of Experimental Sessions 
 
CON Visit – 70 Minute Commitment 
 
Date of Test: 
 




• Cease food consumption and water only after _______ on _________ 
• Cease consumption of any caffeinated beverages after _______ on _________ 
• Cease consumption of alcoholic beverages after _______ on _________ 
• No vigorous exercise after _______ on _________ 
Time (mins) Action EXAMPLE START TIME 
-30:00 - -25:00 Anthropometrics 10:15 AM 
-25:00 Begin Supine Rest 10:20 AM 
-25:00 - -15:00 Affix devices to participant. 10:20 AM 
-15:00 End Supine Rest.  
Begin sitting period. 10:30 AM 
-15:00 - -5:00 Ultrasound data collection 10:30 AM 
-15:00 - -5:00 VICORDER® data collection 10:30 AM 
-5:00 - 0:00 Mental Arithmetic Test 10:40 AM 
00:00 - 1:00 VICORDER® data collection 10:45 AM 
5:00 - 20:00 VICORDER® data collection 10:50 AM 
25:00 - 30:00 VICORDER® data collection 11:10 AM 
30:00 - 40:00 Cognitive tests 11:15 AM 
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SMS Visit – 180 Minute Commitment 
 
Date of Test: 
 
 




• Cease food consumption and water only after _______ on _________ 
• Cease consumption of any caffeinated beverages after _______ on _________ 
• Cease consumption of alcoholic beverages after _______ on _________ 
• No vigorous exercise after _______ on _________ 
• Wake up from sleeping at _______ on _________ 
Time (mins) Action EXAMPLE START 
TIME 
-140:00 - -135:00 Anthropometrics 8:25 AM 
-135:00 Begin Supine Rest 8:30 AM 
-135:00 - -125:00 Affix devices to participant. Collect path 
lengths required for measures from PWV/A 8:30 AM 
-125:00 End Supine Rest. Begin continuous data 
collection from devices. 
Begin prolonged sitting period  
8:40 AM 
 -120:00 -115:00 Ultrasound data collection 8:45 AM 
-115:00 - -110:00 VICORDER® data collection 8:50 AM 
-20:00 - -15:00 Ultrasound data collection 10:25 AM 
-15:00 - -5:00 VICORDER® data collection 10:30 AM 
-5:00 End prolonged sitting period 10:40 AM 
-5:00 – 0:00 Mental Arithmetic Test 10:40 AM 
00:00-1:00 VICORDER® data collection 10:45 AM 
5:00-20:00 VICORDER® data collection 10:50 AM 
25:00-30:00 VICORDER® data collection 11:10 AM 




II. Use of ActiGraph and Accelerometry 
 
The red wearable device we provided to you is called an accelerometer. The brand and specific 
device name are called an ActiGraph. Consider it a “research-grade” smart watch that has a far 
stronger ability to assess physical activity throughout your day. We are using it in this study to 
ensure your that your ambient physical activity is not affecting the results of the study. 
 
When you receive the ActiGraph after this Familiarization session, we ask that you wear the 
monitor on the non-dominant wrist for at least 10 of your waking hours. The monitor records 
activity and sleep throughout your entire involvement in the study. There are no moving parts, 
displays, or buttons, so there is no need to switch the monitor on or off, or reset it.  
 
The monitor automatically starts measuring _________, ____________ and stops on 
_________, ____________.  
 
Please read the following instructions carefully… 
 
1. Put the activity monitor on your non-dominant wrist. The monitor should sit securely in 
position, without being so tight that it is uncomfortable, and without being so loose that it 
is moving about when you are walking or doing any other activities. WEAR THE 
MONITOR ALL DAY AND ALL NIGHT. 
 
2. If you are involved in full contact sports e.g. rugby etc. then the monitor should also be 
removed as it may get damaged and could cause injury. 
 
3. The monitor is water resistant to 1 meter for 30 minutes. This means the monitor may be 
worn during showering, but not for water-based activities such as swimming. Please 
remove the monitor during the water activity then immediately put the monitor back on. It 
may be easier to remember to put the monitor back on if you leave it, for example, on 
your towel or clothes.  Please RECORD THE TIMES THAT YOU REMOVED THE 
MONITOR on the log sheet on the opposite page. 
 
4. PLEASE USE THE LOG SHEET ATTACHED to write down “BGN” and “FSH” times as 
well as when REMOVING AND REPLACING THE MONITOR (e.g. when swimming). 
“BGN” refers to the time when you lie in bed and begin trying to sleep (not reading or 
watching television). “FSH” refers to the time when you finish sleeping and get out of 
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APPENDIX D: MENTAL ARITHMETIC TEST 
 
Mental Arithmetic Test: 
For _______ on ___/____/____ 
 
Script: My name is _______ and I am a research associate for this study, and I will be 
conducting this acuity test. The mental arithmetic test, or MAT for short, is a standardized 
assessment to review individual mathematical acuity. You will be asked to subtract 7 from a 
four-digit number for five minutes with the tempo. Every minute, the initial four-digit number will 
be changed. Your performance on this test is being recorded for post-test analysis and eventual 
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Mental Arithmetic Test: For _______ on ___/____/____ 
 
Script: My name is _______ and I am a research associate for this study, and I will be 
conducting this acuity test. The mental arithmetic test, or MAT for short, is a standardized 
assessment to review individual mathematical acuity. You will be asked to subtract 13 from a 
four-digit number for five minutes with the tempo. Every minute, the initial four-digit number will 
be changed. Your performance on this test is being recorded for post-test analysis and eventual 
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